Hypoplastic left heart syndrome: Difference between revisions
No edit summary |
m (Robot: Changing Category:Disease state to Category:Disease) |
||
Line 44: | Line 44: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Disease | [[Category:Disease]] | ||
[[Category:Neonatology]] | [[Category:Neonatology]] | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Revision as of 20:42, 9 December 2011
Hypoplastic left heart syndrome | ||
Diagram of a healthy heart and one suffering from Hypoplastic left heart syndrome | ||
ICD-10 | Q23.4 | |
ICD-9 | 746.7 | |
OMIM | 241550 | |
DiseasesDB | 31507 | |
MedlinePlus | 001106 | |
MeSH | C14.240.400.625 |
Hypoplastic left heart syndrome Microchapters |
Differentiating Hypoplastic left heart syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypoplastic left heart syndrome On the Web |
American Roentgen Ray Society Images of Hypoplastic left heart syndrome |
Directions to Hospitals Treating Hypoplastic left heart syndrome |
Risk calculators and risk factors for Hypoplastic left heart syndrome |
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S.[2], Cafer Zorkun, M.D., Ph.D. [3], Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S.[5]
Overview
Pathophysiology
Epidemiology and demographics
Natural history, Complications, and Prognosis
Causes
Differentiating Hypoplastic left heart syndrome from other Disorders
Diagnosis
History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical: Medical Therapy
Surgical: Surgery
Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies